# 4D Molecular Therapeutics, Inc.: filings

FDMT · Nasdaq · CIK 1650648 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fdmt.md) · [Financials](/companies/fdmt/financials.md) · [Filings](/companies/fdmt/filings.md) · [Insiders](/companies/fdmt/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 142, 8-K 66, 144 30, SC 13G/A 28, 3 26, 10-Q 17, SCHEDULE 13G/A 14, SC 13G 12, CORRESP 10, S-8 8, EFFECT 7, UPLOAD 7, 10-K 6, 424B5 6, DEF 14A 6, DEFA14A 6, S-3 4, ARS 3, D 3, DRS 3, S-1 3, 3/A 2, 424B4 2, S-1/A 2, SCHEDULE 13G 2, SEC STAFF LETTER 2, 144/A 1, 8-A12B 1, CERT 1, DRS/A 1, FWP 1, POS AM 1, POSASR 1, RW 1, S-1MEF 1, S-3ASR 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-28 | 12:05 ET | [8-K](/filings/0001193125-26-403424.md) | 8.01 Other events | 0001193125-26-403424 |
| 2026-08-13 | 20:09 ET | [10-Q](/filings/0001193125-26-349173.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349173 |
| 2026-08-13 | 20:06 ET | [8-K](/filings/0001193125-26-349160.md) | 2.02 Results of operations | 0001193125-26-349160 |
| 2026-07-20 | 12:30 ET | [8-K](/filings/0001193125-26-308409.md) | 8.01 Other events | 0001193125-26-308409 |
| 2026-06-29 | 12:05 ET | [8-K](/filings/0001193125-26-286880.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-286880 |
| 2026-06-22 | 20:21 ET | [8-K](/filings/0001193125-26-277563.md) | 5.07 Shareholder vote results | 0001193125-26-277563 |
| 2026-05-07 | 20:13 ET | [10-Q](/filings/0001193125-26-211939.md) | Quarterly report, period 2026-03-31 | 0001193125-26-211939 |
| 2026-05-07 | 20:10 ET | [8-K](/filings/0001193125-26-211904.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211904 |
| 2026-04-28 | 20:05 ET | [DEF 14A](/filings/0001140361-26-017427.md) | Proxy statement, period 2026-06-17 | 0001140361-26-017427 |
| 2026-03-30 | 21:29 ET | [8-K](/filings/0001193125-26-131739.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-131739 |
| 2026-03-18 | 20:29 ET | [10-K](/filings/0001193125-26-114075.md) | Annual report, period 2025-12-31 | 0001193125-26-114075 |
| 2026-03-18 | 20:09 ET | [8-K](/filings/0001193125-26-113949.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-113949 |
| 2026-01-26 | 21:05 ET | [8-K](/filings/0001193125-26-022559.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-26-022559 |
| 2026-01-07 | 13:05 ET | [8-K](/filings/0001193125-26-005470.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0001193125-26-005470 |
| 2025-12-10 | 21:06 ET | [8-K](/filings/0001193125-25-314167.md) | 8.01 Other events | 0001193125-25-314167 |
| 2025-11-17 | 11:05 ET | [8-K](/filings/0001193125-25-283861.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-283861 |
| 2025-11-10 | 13:19 ET | [10-Q](/filings/0001193125-25-273343.md) | Quarterly report, period 2025-09-30 | 0001193125-25-273343 |
| 2025-11-10 | 13:17 ET | [8-K](/filings/0001193125-25-273340.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-273340 |
| 2025-11-07 | 21:01 ET | [8-K](/filings/0001193125-25-272286.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-272286 |
| 2025-11-06 | 11:02 ET | [8-K](/filings/0001193125-25-267934.md) | 2.02 Results of operations; 8.01 Other events | 0001193125-25-267934 |
| 2025-10-31 | 10:02 ET | [8-K](/filings/0001193125-25-259302.md) | 1.01 Entry into a material agreement | 0001193125-25-259302 |
| 2025-10-02 | 20:04 ET | [8-K](/filings/0001193125-25-228289.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-228289 |
| 2025-08-11 | 12:07 ET | [10-Q](/filings/0000950170-25-106244.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106244 |
| 2025-08-11 | 12:05 ET | [8-K](/filings/0000950170-25-106243.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-106243 |
| 2025-07-02 | 20:12 ET | [8-K](/filings/0000950170-25-092964.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0000950170-25-092964 |
| 2025-06-20 | 20:03 ET | [8-K](/filings/0000950170-25-088482.md) | 5.07 Shareholder vote results | 0000950170-25-088482 |
| 2025-05-08 | 20:21 ET | [10-Q](/filings/0000950170-25-067040.md) | Quarterly report, period 2025-03-31 | 0000950170-25-067040 |
| 2025-05-08 | 20:16 ET | [8-K](/filings/0000950170-25-067013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-067013 |
| 2025-04-29 | 20:05 ET | [DEF 14A](/filings/0001140361-25-016307.md) | Proxy statement, period 2025-06-17 | 0001140361-25-016307 |
| 2025-02-28 | 21:27 ET | [10-K](/filings/0000950170-25-030056.md) | Annual report, period 2024-12-31 | 0000950170-25-030056 |
| 2025-02-28 | 21:15 ET | [8-K](/filings/0000950170-25-030020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-030020 |
| 2025-02-10 | 13:37 ET | [8-K](/filings/0000950170-25-016708.md) | 8.01 Other events | 0000950170-25-016708 |
| 2025-01-10 | 13:36 ET | [8-K](/filings/0000950170-25-003832.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-003832 |
| 2024-12-11 | 21:15 ET | [8-K](/filings/0000950170-24-135381.md) | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-24-135381 |
| 2024-11-13 | 21:27 ET | [10-Q](/filings/0000950170-24-126370.md) | Quarterly report, period 2024-09-30 | 0000950170-24-126370 |
| 2024-11-13 | 21:17 ET | [8-K](/filings/0000950170-24-126346.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-126346 |
| 2024-09-18 | 20:06 ET | [8-K](/filings/0001193125-24-221375.md) | 8.01 Other events | 0001193125-24-221375 |
| 2024-08-08 | 20:15 ET | [10-Q](/filings/0000950170-24-094010.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094010 |
| 2024-08-08 | 20:14 ET | [8-K](/filings/0000950170-24-093992.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093992 |
| 2024-07-23 | 10:04 ET | [8-K](/filings/0001193125-24-182544.md) | 7.01 Regulation FD disclosure | 0001193125-24-182544 |
| 2024-07-17 | 10:04 ET | [8-K](/filings/0001193125-24-179950.md) | 8.01 Other events | 0001193125-24-179950 |
| 2024-06-07 | 21:07 ET | [8-K](/filings/0001193125-24-157521.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-157521 |
| 2024-05-24 | 20:28 ET | [8-K](/filings/0001193125-24-147093.md) | 5.07 Shareholder vote results | 0001193125-24-147093 |
| 2024-05-09 | 20:22 ET | [8-K](/filings/0000950170-24-057035.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-057035 |
| 2024-05-09 | 20:09 ET | [10-Q](/filings/0000950170-24-056933.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056933 |
| 2024-04-10 | 20:05 ET | [DEF 14A](/filings/0001140361-24-019090.md) | Proxy statement, period 2024-05-21 | 0001140361-24-019090 |
| 2024-02-29 | 21:38 ET | [10-K](/filings/0000950170-24-023183.md) | Annual report, period 2023-12-31 | 0000950170-24-023183 |
| 2024-02-29 | 21:12 ET | [8-K](/filings/0000950170-24-023088.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023088 |
| 2024-02-09 | 21:56 ET | [8-K](/filings/0001193125-24-030203.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-030203 |
| 2024-01-04 | 13:30 ET | [8-K](/filings/0001193125-24-001977.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-001977 |

Page 1 of 2. [Older](/companies/fdmt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.